✦ LIBER ✦

Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children

✍ Scribed by Yuji Yasuda; Ryoya Komatsu; Kenji Matsushita; Taketsugu Minami; Yutaka Suehiro; Hiroshi Sawata; Noriko Nakura; Ralf K. Jaeger; Maria Lattanzi

Book ID: 107648670
Publisher: Springer Healthcare Communications
Year: 2010
Tongue: English
Weight: 395 KB
Volume: 27
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-010-0043-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of the immunogenicity and saf

Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects

✍ Hiroyuki Fukase; Hidetoshi Furuie; Yuji Yasuda; Ryoya Komatsu; Kenji Matsushita; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Safety and immunogenicity of a monovalen

Safety and immunogenicity of a monovalent MF59®-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults

✍ Paolo Palma; Maria Luisa Romiti; Stefania Bernardi; Giuseppe Pontrelli; Nadia Mo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Safety and immunogenicity of an MF59®-ad

Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly

✍ Timo Vesikari; Aino Forstén; Karl-Heinz Herbinger; Giovanni Della Cioppa; Jenny 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB

A Phase III, randomized study to evaluat

A Phase III, randomized study to evaluate the immunogenicity and safety of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in HIV-positive adults

✍ Diaz, Ricardo Sobhie; Tenore, Simone Barros; da Silva, Mônica M. Gomes; da Cunha 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 515 KB

A randomized clinical trial to identify

A randomized clinical trial to identify the optimal antigen and MF59® adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects

✍ Christoph Hatz; Frank von Sonnenburg; Daniela Casula; Maria Lattanzi; Geert Lero 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 668 KB

Dose ranging of adjuvant and antigen in

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial

✍ Wendy Keitel; Nicola Groth; Maria Lattanzi; Michaela Praus; Anne Katrin Hilbert; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 950 KB